
CDP
USDCOPT Defense Properties Common Shares of Beneficial Interest
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$26.490
고가
$26.610
저가
$26.210
거래량
0.16M
기업 기본 정보
시가총액
3.0B
산업
REIT - Office
국가
United States
거래 통계
평균 거래량
1.11M
거래소
NYQ
통화
USD
52주 범위
AI 분석 리포트
마지막 업데이트: 2025년 4월 26일CDP (COPT Defense Properties Common Shares of Beneficial Interest): Analyzing Recent Moves & What Might Come Next
Stock Symbol: CDP Generate Date: 2025-04-26 18:56:53
Let's break down what's been happening with COPT Defense Properties and what the data suggests could be on the horizon. Think of this as looking under the hood to see the key drivers right now.
Recent News Buzz: What's the Vibe?
The news flow for CDP lately seems pretty positive overall.
First off, the company announced when they'll share their first-quarter 2025 results and hold a call to talk about them. This is standard stuff, just setting the date for investors to hear how things went. It's neutral news on its own, but it means we'll get a clearer picture soon.
The bigger news came earlier, back in March. A firm called Jefferies started covering CDP and slapped a "Buy" rating on the stock. Not only that, but their analyst put a price target of $31 on it. That's a solid vote of confidence from a professional analyst, suggesting they see good potential for the stock price to climb from where it was then (and where it is now). This kind of analyst upgrade often gives investors a positive feeling about a stock.
Price Check: What's the Stock Been Doing?
Looking at the price chart over the past few months, CDP has seen a bit of a rollercoaster. It started the year around the $29-$30 mark. Then, through February and into March, it drifted lower, hitting lows around $26. For most of March and early April, the price bounced around, mostly staying between $26 and $27.
More recently, in April, we saw another dip, with the price briefly falling below $25. However, it's since recovered somewhat and is currently trading back in the mid-$26 range. The last recorded price was $26.36. So, the recent trend has been a bit choppy, with a dip followed by a partial recovery, leaving it below where it started the year but above its recent lows.
Now, let's look at the AI's take on the immediate future. The AI model predicts the price will stay roughly flat today (0.00% change from the starting point it used). But then, it forecasts a noticeable jump: a 3.81% increase the next day, followed by another 4.67% rise the day after that. That's a pretty optimistic short-term outlook from the AI, suggesting it expects the stock to move upwards significantly from its current level very soon.
Putting It Together: Outlook & Ideas
Based on the positive analyst rating, the recent price recovery from April lows, and especially the AI's strong prediction for the next couple of days, the apparent near-term leaning seems to favor potential buyers.
Why? The analyst thinks the stock is worth more ($31 target), and the AI model is forecasting a quick upward move right from the current price area. While the historical chart shows some recent weakness, the combination of positive sentiment (analyst) and bullish prediction (AI) suggests things might be turning around.
Potential Entry Consideration: If you were considering getting into this stock, the current price area, around the last close of $26.36, looks like the starting point for the AI's predicted move. The recommendation data also points to levels like $26.54 or $26.63 as potential entry spots, which are right around where it's trading now or slightly higher. This area seems interesting because it aligns with where the AI expects the upward trend to begin and is near a noted support level ($26.44).
Potential Exit/Stop-Loss Consideration: For managing risk, the recommendation data suggests a stop-loss level at $23.73. This is below the recent lows and the 52-week low, acting as a point to potentially cut losses if the price unexpectedly drops significantly. On the upside, the AI predicts a substantial gain over the next couple of days. The analyst target is $31, which is a much longer-term view. The recommendation data lists a take profit at $26.90, which seems quite conservative given the AI's forecast and analyst target, but it could represent a very short-term target or a partial profit-taking level. If the AI's prediction plays out, you'd likely look for levels higher than $26.90 for more significant gains, perhaps watching for resistance points or aiming towards the analyst's $31 target over time if the trend continues.
Company Context
It's worth remembering that COPT Defense Properties is a REIT focused on properties near U.S. government defense sites. This means its business is tied closely to government spending and defense priorities. The analyst's positive view and the stock's performance can be influenced by the stability of its tenant base (the USG and defense contractors) and the outlook for that sector.
Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.
관련 뉴스
COPT Defense Reports First Quarter 2025 Results
EPS of $0.31 FFO per Share, as Adjusted for Comparability, of $0.65 4.8% FFO per Share Growth Year-over-Year Met Midpoint of Guidance Reiterates Midpoint of 2025 FFO per Share Guidance of $2.66 Implies 3.5% FFO per
COPT Defense Executes Two Investment Leases in Redstone Gateway Totaling 55,000 SF, Bringing Total Portfolio Year-to-Date Investment Leasing to 103,000 SF
COPT Defense Properties (NYSE:CDP) ("COPT Defense" or the "Company") has executed two investment leases in Redstone Gateway totaling 55,000 square feet, bringing the total portfolio year-to-date investment leasing to
AI 예측Beta
AI 추천
업데이트 시간: 2025년 4월 28일 오후 08:23
68.2% 신뢰도
리스크 & 트레이딩
진입점
$26.54
익절
$26.90
손절
$23.73
핵심 요소
관련 주식

XELAP
Exela Technologies Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock

MVST
Microvast Holdings Inc.

DRMAW
Dermata Therapeutics Inc. Warrant

JBK
Lehman ABS 3.50 3.50% Adjustable Corp Backed Tr Certs GS Cap I

BFC
Bank First Corporation
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기